IDEAS home Printed from https://ideas.repec.org/a/plo/pmed00/1004252.html
   My bibliography  Save this article

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study

Author

Listed:
  • Allison Portnoy
  • Jean-Louis Arcand
  • Rebecca A Clark
  • Chathika K Weerasuriya
  • Christinah Mukandavire
  • Roel Bakker
  • Edith Patouillard
  • Nebiat Gebreselassie
  • Matteo Zignol
  • Mark Jit
  • Richard G White
  • Nicolas A Menzies

Abstract

Background: Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on gross domestic product (GDP) growth in 105 LMICs. Methods and findings: We adapted an existing macroeconomic model to simulate country-level GDP trends between 2020 and 2080, comparing scenarios for introduction of hypothetical infant and adolescent/adult vaccines to a no-new-vaccine counterfactual. We parameterized each scenario using estimates of TB-related mortality, morbidity, and healthcare spending from linked epidemiological and costing models. We assumed vaccines would be introduced between 2028 and 2047 and estimated incremental changes in GDP within each country from introduction to 2080, in 2020 US dollars. We tested the robustness of results to alternative analytic specifications. Both vaccine scenarios produced greater cumulative GDP in the modeled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8, 3.0) trillion for the adolescent/adult vaccine and $0.2 ($0.1, 0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, particularly for the infant vaccine. GDP gains resulting from vaccine introduction were concentrated in countries with higher current TB incidence and earlier vaccine introduction. Results were sensitive to secular trends in GDP growth but relatively robust to other analytic assumptions. Uncertain projections of GDP could alter these projections and affect the conclusions drawn by this analysis. Conclusions: Under a range of assumptions, introducing novel TB vaccines would increase economic growth in LMICs. Why was this study done?: What did the researchers do and find?: What do these findings mean?:

Suggested Citation

  • Allison Portnoy & Jean-Louis Arcand & Rebecca A Clark & Chathika K Weerasuriya & Christinah Mukandavire & Roel Bakker & Edith Patouillard & Nebiat Gebreselassie & Matteo Zignol & Mark Jit & Richard G , 2023. "The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study," PLOS Medicine, Public Library of Science, vol. 20(7), pages 1-18, July.
  • Handle: RePEc:plo:pmed00:1004252
    DOI: 10.1371/journal.pmed.1004252
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004252
    Download Restriction: no

    File URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004252&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pmed.1004252?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Allison Portnoy & Kelsey Vaughan & Emma Clarke-Deelder & Christian Suharlim & Stephen C. Resch & Logan Brenzel & Nicolas A. Menzies, 2020. "Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates," PharmacoEconomics, Springer, vol. 38(9), pages 995-1005, September.
    2. Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark E. & Oxley, Les & Prettner, Klaus, 2020. "The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea," The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
    3. Bloom, David E. & Cafiero-Fonseca, Elizabeth T. & McGovern, Mark E. & Prettner, Klaus & Stanciole, Anderson & Weiss, Jonathan & Bakkila, Samuel & Rosenberg, Larry, 2014. "The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons," The Journal of the Economics of Ageing, Elsevier, vol. 4(C), pages 100-111.
    4. Allison Portnoy & Rebecca A Clark & Matthew Quaife & Chathika K Weerasuriya & Christinah Mukandavire & Roel Bakker & Arminder K Deol & Shelly Malhotra & Nebiat Gebreselassie & Matteo Zignol & So Yoon , 2023. "The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study," PLOS Medicine, Public Library of Science, vol. 20(1), pages 1-18, January.
    5. Ronald L. Iman & Jon C. Helton, 1988. "An Investigation of Uncertainty and Sensitivity Analysis Techniques for Computer Models," Risk Analysis, John Wiley & Sons, vol. 8(1), pages 71-90, March.
    6. Smith, Richard D. & Yago, Milton & Millar, Michael & Coast, Jo, 2005. "Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance," Journal of Health Economics, Elsevier, vol. 24(6), pages 1055-1075, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark E. & Oxley, Les & Prettner, Klaus, 2020. "The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea," The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
    2. Simiao Chen & Michael Kuhn & Klaus Prettner & David E Bloom, 2018. "The macroeconomic burden of noncommunicable diseases in the United States: Estimates and projections," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-14, November.
    3. Hafner, Marco & Yerushalmi, Erez & Andersson, Fredrik L. & Burtea, Teodor, 2020. "Quantifying the macroeconomic cost of night-time bathroom visits: an application to the UK," CAFE Working Papers 5, Centre for Accountancy, Finance and Economics (CAFE), Birmingham City Business School, Birmingham City University.
    4. S. Cucurachi & E. Borgonovo & R. Heijungs, 2016. "A Protocol for the Global Sensitivity Analysis of Impact Assessment Models in Life Cycle Assessment," Risk Analysis, John Wiley & Sons, vol. 36(2), pages 357-377, February.
    5. Annarita BALDANZI & Alberto BUCCI & Klaus PRETTNER, 2016. "The Effects of Health Investments on Human Capital and R&D-Driven Economic Growth," Departmental Working Papers 2016-17, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.
    6. Md. Mahmudul Alam & Haitian Wei & Abu N. M. Wahid, 2021. "COVID‐19 outbreak and sectoral performance of the Australian stock market: An event study analysis," Australian Economic Papers, Wiley Blackwell, vol. 60(3), pages 482-495, September.
    7. Chen, Simiao & Prettner, Klaus & Kuhn, Michael & Bloom, David E., 2021. "The economic burden of COVID-19 in the United States: Estimates and projections under an infection-based herd immunity approach," The Journal of the Economics of Ageing, Elsevier, vol. 20(C).
    8. Aysit Tansel & Ceyhan Ozturk & Erkan Erdil, 2021. "The Impact of Body Mass Index on Growth, Schooling, Productivity, and Savings: A Cross-Country Study," Koç University-TUSIAD Economic Research Forum Working Papers 2118, Koc University-TUSIAD Economic Research Forum.
    9. repec:plo:pone00:0070578 is not listed on IDEAS
    10. Domenico Delli Gatti & Severin Reissl & Enrico Turco, 2023. "V for vaccines and variants," Journal of Evolutionary Economics, Springer, vol. 33(4), pages 991-1046, September.
    11. Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan, 2019. "Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2019-03, Centre for Competition Policy, University of East Anglia, Norwich, UK..
    12. Ahmed, S. Amer & Baris, Enis & Go, Delfin S & Lofgren, Hans & Osorio Rodarte, Israel & Thierfelder, Karen, 2017. "Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance," Conference papers 332903, Purdue University, Center for Global Trade Analysis, Global Trade Analysis Project.
    13. Baldanzi, Annarita & Bucci, Alberto & Prettner, Klaus, 2021. "Children’S Health, Human Capital Accumulation, And R&D-Based Economic Growth," Macroeconomic Dynamics, Cambridge University Press, vol. 25(3), pages 651-668, April.
    14. Pape Yona Boubacar Mane & Abdoulaye Diagne & Yao thibaut Kpegli, 2019. "Modeling the Macroeconomic Effects of Disease: Extension and Application in the context of Senegal," Economics Bulletin, AccessEcon, vol. 39(4), pages 2904-2912.
    15. George Verikios & Maura Sullivan & Pane Stojanovski & James Giesecke & Gordon Woo, 2016. "Assessing Regional Risks From Pandemic Influenza: A Scenario Analysis," The World Economy, Wiley Blackwell, vol. 39(8), pages 1225-1255, August.
    16. Smith, Richard D., 2006. "Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management," Social Science & Medicine, Elsevier, vol. 63(12), pages 3113-3123, December.
    17. Lee, Sang-Hee & Park, Cheol-Min, 2022. "The effect of hunter-wild boar interactions and landscape heterogeneity on wild boar population size: A simulation study," Ecological Modelling, Elsevier, vol. 464(C).
    18. Ahmed, Syud Amer & Barış, Enis & Go, Delfin S. & Lofgren, Hans & Osorio-Rodarte, Israel & Thierfelder, Karen, 2018. "Assessing the global poverty effects of antimicrobial resistance," World Development, Elsevier, vol. 111(C), pages 148-160.
    19. Shabbir Ahmed Osmani & Foysol Mahmud, 2021. "An integrated approach of machine algorithms with multi-objective optimization in performance analysis of event detection," Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development, Springer, vol. 23(2), pages 1976-1993, February.
    20. Marcus R. Keogh‐Brown & Simon Wren‐Lewis & W. John Edmunds & Philippe Beutels & Richard D. Smith, 2010. "The possible macroeconomic impact on the UK of an influenza pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 19(11), pages 1345-1360, November.
    21. Eswaran, Mukesh & Gallini, Nancy, 2017. "Can Competition Extend the Golden Age of Antibiotics?," Microeconomics.ca working papers -2017-9, Vancouver School of Economics, revised 19 Oct 2017.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1004252. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.